Mouse models of neurofibromatosis type I: bridging the GAP

Author： Costa R.M.   Silva A.J.  

Publisher： Elsevier

ISSN： 1471-4914

Source： Trends in Molecular Medicine, Vol.9, Iss.1, 2003-01, pp. : 19-23

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Neurofibromatosis type I and smoldering multiple myeloma: A case report

By Danilatou Vassiliki   Liapi Demetra   Psyllaki Maria   Chatzivasili Aria   Chronaki Irini   Heliakis Polyvios  

Hematology, Vol. 11, Iss. 1, 2006-02 ,pp. : 45-48

Maney Publishing

Access to resources Recommend Favorite

Bridging the disability gap with distance learning

By Coombs N.  

Technology and Disability, Vol. 8, Iss. 3, 1998-07 ,pp. : 149-152

Elsevier

Access to resources Recommend Favorite

The mechanism of LPS-induced HIV type I activation in transgenic mouse macrophages

By Kadoki Motohiko   Choi Byung-Il   Iwakura Yoichiro  

International Immunology, Vol. 22, Iss. 6, 2010-06 ,pp. : 469-478

Oxford University Press

Access to resources Recommend Favorite

Developmental Abnormalities and Cancer Predisposition in Neurofibromatosis Type 1

By  

Current Molecular Medicine, Vol. 9, Iss. 5, 2009-06 ,pp. : 634-653

Bentham Science Publishers

Access to resources Recommend Favorite

Establishment and comparison of delayed-type hypersensitivity models in the B6C3F1 mouse

By Smith Matthew J.   White Kimber L.  

Journal of Immunotoxicology, Vol. 7, Iss. 4, 2010-12 ,pp. : 308-317

Informa Healthcare

Access to resources Recommend Favorite